Misclassification of Variants As Pathogenic in Black Americans

Share this content:
Misclassification of Variants As Pathogenic in Black Americans
Misclassification of Variants As Pathogenic in Black Americans

THURSDAY, Aug. 18, 2016 (HealthDay News) -- Variants that have previously been considered causal in hypertrophic cardiomyopathy are often misclassified as pathogenic in patients with African or unspecified ancestry, according to a study published in the Aug. 18 issue of the New England Journal of Medicine.

Arjun K. Manrai, Ph.D., from Harvard Medical School in Boston, and colleagues identified variants that have previously been considered causal in hypertrophic cardiomyopathy and are overrepresented in the general population. These variants were studied in diverse populations and reevaluated in the medical literature. Patient records at a leading genetic-testing laboratory were reviewed for occurrences of these variants.

The researchers found that multiple patients of African or unspecified ancestry received positive reports, with variants misclassified as pathogenic. On subsequent re-categorization, all variants were benign. The most common mutations in the general population were significantly more common among black than white Americans (P < 0.001). These misclassifications probably would have been prevented by inclusion of even small numbers of black Americans in control cohorts.

"These results expand on current guidelines, which recommend the use of ancestry-matched controls to interpret variants," the authors write. "As additional populations of different ancestry backgrounds are sequenced, we expect variant reclassifications to increase, particularly for ancestry groups that have historically been less well studied."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

SABCS: Artificial Intelligence May Aid Doctors in Breast Cancer Care

SABCS: Artificial Intelligence May Aid Doctors in Breast ...

'Watson Oncology' agreed with doctors 90 percent of the time in many cases, researchers find

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

Devices reduce blood flow to hair follicles during chemotherapy treatments

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

Women on aromatase inhibitors exhibit less elasticity in their blood vessels

is free, fast, and customized just for you!

Already a member?

Sign In Now »